Dexmedetomidine 5 micrograms is one of 45 small molecule programs targeting Glaucoma. It is currently in Preclinical.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
54 competitors in Glaucoma
Travatan
Alphagan
Zolymbus
Xalatan
Diamox
Crestor
Timolol Maleate
Neoral
Isopto Carpine
Decadron
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details